BC3 Technologies has received a U.S. patent that protects its proprietary material, chemistry, technology, and method of its product SEAL Hemostatic Wound Spray for rapid and efficient management of severe bleeding.
BC3 Technologies has received a U.S. patent that protects its proprietary material, chemistry, technology, and method of its product SEAL Hemostatic Wound Spray for rapid and efficient management of severe bleeding.